Trial Profile
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2022
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 02 Aug 2021 Status changed from active, no longer recruiting to completed.
- 02 Sep 2020 Planned End Date changed from 1 Dec 2021 to 1 Mar 2021.
- 02 Sep 2020 Planned primary completion date changed from 1 Jul 2020 to 1 Mar 2021.